Biotech Values

[DewDiligence]

Re: MNTA CC notes /Glatopa pricing

The $35K Glatopa price mentioned on the CC for modeling purposes is a 25% discount to Teva’s actual realized price of $47K for US patient taking branded 20mg Copaxone for one year.

The $47K figure comes from multiplying Teva’s list price of $73K by 80% to account for rebates and then multiplying by another 80% to account for non-compliance (i.e. patients who have treatment lapses from not filling their prescriptions).